REPLIMUNE GROUP, INC. Increase (Decrease) in Other Noncurrent Liabilities
REPLIMUNE GROUP, INC. (REPL) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-14
- REPLIMUNE GROUP, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was $0.00.
- REPLIMUNE GROUP, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $97.00K.
- REPLIMUNE GROUP, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$268.00K, a 155.83% decline year-over-year.
- REPLIMUNE GROUP, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $0.00.
- REPLIMUNE GROUP, INC. increase (decrease) in other noncurrent liabilities for fiscal 2026 was -$487.00K, a 414.19% decline from fiscal 2025.
- REPLIMUNE GROUP, INC. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $155.00K, a 50.64% decline from fiscal 2024.
- REPLIMUNE GROUP, INC. increase (decrease) in other noncurrent liabilities for fiscal 2024 was $314.00K, a 33.47% decline from fiscal 2023.
- REPLIMUNE GROUP, INC. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $472.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $97.00K derived: sum of 2 quarters · filed 2026-08-14 | -$171.00K derived: sum of 3 quarters · filed 2026-08-14 | -$171.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | -$171.00K derived: sum of 2 quarters · filed 2026-06-29 | -$171.00K derived: sum of 3 quarters · filed 2026-06-29 | -$487.00K 10-K · filed 2026-06-29 |
| 2025-12-31 | -$268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | -$268.00K derived: sum of 2 quarters · filed 2026-02-03 | -$584.00K 10-Q · filed 2026-02-03 | -$909.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$316.00K 10-Q · filed 2025-11-06 | -$641.00K derived: sum of 3 quarters · filed 2026-08-14 | -$161.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$316.00K 10-Q · filed 2026-08-14 | -$641.00K derived: sum of 2 quarters · filed 2026-08-14 | -$161.00K derived: sum of 3 quarters · filed 2026-08-14 | -$161.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$325.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $155.00K derived: sum of 2 quarters · filed 2026-06-29 | $155.00K derived: sum of 3 quarters · filed 2026-06-29 | $155.00K 10-K · filed 2026-06-29 |
| 2024-12-31 | $480.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | $480.00K derived: sum of 2 quarters · filed 2026-02-03 | $480.00K 10-Q · filed 2026-02-03 | $474.00K derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | -$6.00K derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | -$6.00K derived: sum of 2 quarters · filed 2025-08-07 | ||
| 2024-03-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $314.00K 10-K · filed 2025-05-22 | ||
| 2023-12-31 | $320.00K 10-Q · filed 2025-02-12 | |||
| 2023-06-30 | $107.00K 10-Q · filed 2024-08-08 | $579.00K derived: sum of 2 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $472.00K 10-K · filed 2024-05-16 | ||
| 2022-12-31 | $0.00 10-Q · filed 2024-02-08 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | $0.00 10-K · filed 2023-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |